Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
862.6 DKK | -0.01% | -2.07% | +23.45% |
Apr. 18 | India's Biocon developing its own version of Wegovy, clinical trial likely next year | RE |
Apr. 15 | More than 250 websites selling fake weight-loss drugs reported by anti-counterfeit firm | RE |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.45% | 550B | |
+27.97% | 672B | |
-7.02% | 351B | |
+14.85% | 317B | |
+6.25% | 292B | |
+2.47% | 211B | |
-0.38% | 203B | |
-9.94% | 194B | |
-11.81% | 144B | |
-8.80% | 141B |
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- Transcript : Novo Nordisk A/S, 2021 Earnings Call, Feb 02, 2022